Specifically, active caspase-3 results in the degradation of actomyosin complexes, and inhibition of caspase-3 activity suppresses the overall rate of proteolysis in diabetes-mediated cachexia and disuse-induced muscle atrophy [51–53]. The gene discussed is CASP3; the disease is muscle atrophy.